Pepsinogen is activated by:
Which of the following prevents GERD?
Which of the following regulators would MOST likely inhibit the lower esophageal sphincter in normal individuals?
Enterohepatic circulation occurs in which part of the small intestine?
Resting tone of the rectum is decreased in all conditions except?
Glucose absorption from the gastrointestinal tract occurs by which mechanism?
What function does the myenteric plexus in the gastrointestinal tract primarily control?
Migratory motor complex is initiated by which hormone?
Which of the following statements about secretin is FALSE?
The success of oral rehydration therapy in diarrhea depends upon which of the following processes in the intestinal mucosa?
Explanation: **Explanation:** **1. Why Low pH is Correct:** Pepsinogen is a proenzyme (zymogen) secreted by the **Chief cells** (Peptic cells) of the stomach. It is biologically inactive to prevent the autodigestion of gastric mucosa. Activation occurs in the gastric lumen through two steps: * **Acid Activation:** When gastric pH falls below **3.5** (ideally between 1.8 and 2.5) due to HCl secreted by Parietal cells, a conformational change occurs. This causes the pepsinogen molecule to cleave itself, removing a protective amino acid mask to form active **Pepsin**. * **Autocatalysis:** Once a small amount of pepsin is formed, it further activates more pepsinogen molecules. **2. Why Other Options are Incorrect:** * **Enterokinase (A):** This enzyme is located on the duodenal brush border. Its specific role is to activate **Trypsinogen into Trypsin**. It does not act on gastric enzymes. * **Trypsin (C) & Chymotrypsin (D):** These are pancreatic proteases active in the alkaline environment of the small intestine. While Trypsin activates other pancreatic zymogens (like procarboxypeptidase), it has no role in the activation of gastric pepsinogen. **3. High-Yield Clinical Pearls for NEET-PG:** * **Optimal pH:** Pepsin is most active at pH **1.8–3.5**. It becomes irreversibly inactivated when the pH rises above **7.0** (e.g., when gastric contents enter the duodenum). * **Vagal Stimulation:** The Vagus nerve stimulates both HCl (Parietal cells) and Pepsinogen (Chief cells) secretion, ensuring both are present simultaneously for protein digestion. * **Achlorhydria:** In conditions like Pernicious Anemia (loss of parietal cells), the lack of HCl leads to a failure in pepsinogen activation, severely impairing gastric protein digestion.
Explanation: **Explanation:** **Gastroesophageal Reflux Disease (GERD)** occurs when the retrograde flow of gastric contents into the esophagus causes symptoms or mucosal damage. The primary physiological barrier preventing this is the **Lower Esophageal Sphincter (LES) tone.** 1. **Why Option A is Correct:** The LES is a specialized smooth muscle zone at the distal esophagus. It maintains a high-pressure zone (resting tone of **10–30 mmHg**) that exceeds intragastric pressure. This tonic contraction, supported by the **crural diaphragm** (acting as an external sphincter) and the **Angle of His**, prevents the acidic gastric contents from entering the esophagus. A decrease in LES tone or transient LES relaxations (TLESRs) is the hallmark of GERD pathophysiology. 2. **Why Other Options are Incorrect:** * **Gastric and Esophageal Mucosa (B & C):** These are anatomical linings. While the esophageal mucosa has some protective mechanisms (bicarbonate secretion), it does not *prevent* reflux; it only attempts to resist damage *after* reflux has occurred. * **Acidic content of stomach (D):** This is the **causative agent** of the symptoms and mucosal injury in GERD, not a preventive factor. **High-Yield Clinical Pearls for NEET-PG:** * **The "Z-line":** The squamocolumnar junction where the esophageal epithelium changes to gastric epithelium. * **Hormonal Influence:** Gastrin increases LES tone, while Secretin, CCK, and Progesterone (as seen in pregnancy) decrease it. * **Barrett’s Esophagus:** A complication of chronic GERD where squamous epithelium undergoes **metaplasia** to specialized columnar epithelium (pre-malignant). * **Gold Standard Investigation:** 24-hour ambulatory pH monitoring.
Explanation: ### Explanation The Lower Esophageal Sphincter (LES) maintains a high-pressure zone to prevent gastroesophageal reflux. Its relaxation is a coordinated reflex mediated by the **myenteric plexus** during swallowing (receptive relaxation). **Why Option D is Correct:** The relaxation of the LES is primarily mediated by **inhibitory non-adrenergic, non-cholinergic (NANC) neurons**. These neurons release **Nitric Oxide (NO)** and **Vasoactive Intestinal Polypeptide (VIP)**. * **Nitric Oxide** acts via cGMP to decrease intracellular calcium, leading to smooth muscle relaxation. * **VIP** works through cAMP pathways to achieve a similar inhibitory effect. Together, they are the principal neurotransmitters responsible for the physiological opening of the LES. **Analysis of Incorrect Options:** * **Option A & C:** **Substance P** is an excitatory neurotransmitter in the GI tract. Along with **Acetylcholine (ACh)**, it promotes smooth muscle contraction and increases LES tone. * **Option B:** While this contains Nitric Oxide (inhibitory), the presence of Substance P (excitatory) makes the combination incorrect for overall inhibition. **NEET-PG High-Yield Pearls:** 1. **Achalasia Cardia:** A clinical condition caused by the failure of LES relaxation due to the loss of NO/VIP-producing inhibitory neurons in the myenteric (Auerbach’s) plexus. 2. **Hormonal Influence:** **Gastrin** increases LES tone (to prevent reflux during digestion), while **Secretin, Cholecystokinin (CCK), and Glucagon** generally decrease it. 3. **Pharmacology:** Calcium channel blockers and Nitrates are used to treat Achalasia because they mimic the inhibitory effect of NO on the LES.
Explanation: **Explanation:** The **enterohepatic circulation** is the process by which bile salts are secreted by the liver into the duodenum, reabsorbed from the intestinal lumen, and returned to the liver via the portal venous system. **Why Distal Ileum is Correct:** While bile salts aid in fat digestion throughout the small intestine, their active reabsorption occurs specifically in the **distal ileum**. This is mediated by the **Apical Sodium-Dependent Bile Acid Transporter (ASBT)**. Approximately 95% of bile salts are recycled this way, while only 5% are lost in feces. This recycling is crucial because the total bile salt pool (approx. 3g) must circulate 6–10 times a day to meet digestive needs. **Why Other Options are Incorrect:** * **Duodenum:** This is the site where bile *enters* the GI tract (via the Ampulla of Vater) to begin emulsification; no significant reabsorption occurs here. * **Jejunum:** This is the primary site for the absorption of nutrients (carbohydrates, proteins, and lipids), but it lacks the specific active transport mechanisms required for bile salt recovery. * **Proximal Ileum:** While some passive diffusion may occur, the density of active transporters (ASBT) is highest in the terminal/distal portion of the ileum. **High-Yield Clinical Pearls for NEET-PG:** * **Ileal Resection:** If the distal ileum is resected (e.g., in Crohn’s disease), bile salt malabsorption occurs, leading to **steatorrhea** (fatty stools) and **Vitamin ADEK deficiency**. * **Choleretic Effect:** The return of bile salts to the liver is the most potent stimulus for further bile secretion. * **Bile Acid Sequestrants:** Drugs like Cholestyramine bind bile acids in the ileum, preventing reabsorption and forcing the liver to use cholesterol to make new bile, thereby lowering LDL levels.
Explanation: **Explanation:** The resting tone of the rectum is primarily maintained by the **internal anal sphincter (IAS)**, which is under involuntary autonomic control. Understanding the physiological response to rectal filling is key to solving this question. **1. Why "Retained feces in the rectum" is the correct answer:** When feces enter the rectum, it triggers the **Recto-anal Inhibitory Reflex (RAIR)**. This reflex causes the internal anal sphincter to relax (decreasing tone) to allow the "sampling" of contents. However, if defecation is voluntarily postponed, the rectum undergoes **receptive relaxation** (accommodation). Over time, if feces are chronically retained, the rectal wall stretches, but the basal resting tone of the sphincter eventually recovers or remains high to prevent fecal incontinence. In chronic constipation/fecal impaction, the resting tone is not decreased; rather, the sensory threshold for defecation increases. **2. Analysis of Incorrect Options:** * **Micturition:** During voiding, there is a coordinated relaxation of the pelvic floor muscles and a physiological decrease in the tone of the anal sphincters (the **guarding reflex** is inhibited) to facilitate the process. * **Rectal Prolapse:** Chronic or complete rectal prolapse is strongly associated with a **patulous (lax) anus**. The constant protrusion of tissue stretches and weakens the internal and external sphincters, leading to a significant decrease in resting tone. * **Trauma involving the perineum:** Direct injury to the perineal body or the sphincteric complex (e.g., obstetric trauma or surgical injury) causes structural damage to the muscles, leading to a permanent or temporary decrease in resting tone and potential fecal incontinence. **High-Yield Clinical Pearls for NEET-PG:** * **Hirschsprung Disease:** Characterized by the **absence of RAIR** (the internal sphincter fails to relax upon rectal distension due to missing ganglion cells). * **Internal Anal Sphincter:** Responsible for **70-85%** of the resting anal pressure. * **External Anal Sphincter:** Under voluntary control (Pudendal nerve, S2-S4) and provides "squeeze pressure."
Explanation: **Explanation:** Glucose absorption in the small intestine is a classic example of **Secondary Active Transport**, specifically utilizing the **SGLT-1 (Sodium-Glucose Co-transporter 1)** protein located on the apical (luminal) membrane of enterocytes. **Why Secondary Active Transport is correct:** This process is "secondary" because it does not use ATP directly. Instead, it relies on the electrochemical gradient created by the **Na⁺-K⁺ ATPase pump** on the basolateral membrane. This pump extrudes 3 Na⁺ ions out of the cell, creating a low intracellular sodium concentration. Glucose then hitches a ride with Na⁺ as it moves down its concentration gradient into the cell via SGLT-1. Once inside the cell, glucose exits into the blood via **GLUT-2** through facilitated diffusion. **Why other options are incorrect:** * **Simple Diffusion:** Glucose is a large, polar molecule and cannot pass through the lipid bilayer without a transporter. * **Facilitated Diffusion:** While **Fructose** is absorbed via facilitated diffusion (using **GLUT-5**), and glucose *exits* the cell via GLUT-2 this way, the primary mechanism for glucose *uptake* from the lumen is active. * **Endocytosis:** This mechanism is used for large macromolecules (like immunoglobulins in neonates), not simple sugars. **High-Yield NEET-PG Pearls:** * **SGLT-1 vs. SGLT-2:** SGLT-1 is primarily in the **intestine**, while SGLT-2 is in the **proximal convoluted tubule** of the kidney. * **Oral Rehydration Solution (ORS):** The physiological basis of ORS is the SGLT-1 transporter; sodium and glucose are co-transported, and water follows osmotically, which is vital in treating secretory diarrheas like Cholera. * **Galactose:** Uses the same SGLT-1 mechanism as glucose.
Explanation: The enteric nervous system (ENS) is often referred to as the "brain of the gut." It consists of two major plexuses located within the walls of the gastrointestinal tract: the **Myenteric (Auerbach’s) plexus** and the **Submucosal (Meissner’s) plexus**. ### Why Option C is Correct: The **Myenteric plexus** is located between the inner circular and outer longitudinal muscle layers of the muscularis externa. Because of its anatomical position, its primary function is the control of **gastrointestinal motility**. When stimulated, it increases the intensity of rhythm, the rate of contraction, and the velocity of conduction of excitatory waves along the gut wall, facilitating peristalsis. ### Why Other Options are Incorrect: * **Option A & B:** These are primarily the functions of the **Submucosal (Meissner’s) plexus**. This plexus is located in the submucosa and is responsible for sensing the luminal environment. It controls **local secretion**, absorption, and **local blood flow** by regulating the contraction of the submucosal muscle and the dilation of local blood vessels. * **Option D:** While both plexuses work together to coordinate GI function, their primary roles are distinct and anatomically segregated. ### High-Yield Clinical Pearls for NEET-PG: * **Auerbach’s = Motility:** Remember "A" for Auerbach’s and "A" for Action/Activity (Motility). * **Meissner’s = Mucosa:** Remember "M" for Meissner’s and "M" for Mucosa (Secretions). * **Hirschsprung Disease:** Caused by the congenital absence of ganglion cells in both plexuses (starting from the anus), leading to a functional obstruction and "megacolon." * **Achalasia Cardia:** Characterized by the loss of inhibitory nitrergic neurons in the myenteric plexus of the lower esophageal sphincter.
Explanation: **Explanation:** The **Migrating Motor Complex (MMC)** is a distinct pattern of electromechanical activity observed in gastrointestinal smooth muscle during the **inter-digestive state** (fasting). Its primary function is to sweep residual undigested food and bacteria from the stomach and small intestine into the colon, often referred to as the "intestinal housekeeper." **Why Motilin is the correct answer:** Motilin, a 22-amino acid peptide secreted by **M-cells** in the duodenal and jejunal mucosa, is the primary hormonal mediator of the MMC. Plasma motilin levels fluctuate cyclically, peaking just before the onset of **Phase III** (the most active contractile phase) of the MMC. Exogenous administration of motilin can induce an MMC, while motilin antagonists inhibit it. **Analysis of Incorrect Options:** * **Gastrin:** Secreted by G-cells, it stimulates gastric acid secretion and mucosal growth. It is released in response to a meal, which actually **terminates** the MMC and initiates the "fed pattern" of motility. * **Cholecystokinin (CCK):** Released in response to fat and protein in the duodenum, CCK stimulates gallbladder contraction and pancreatic enzyme secretion. Like gastrin, it inhibits the MMC to allow for digestion. * **Vasoactive Intestinal Peptide (VIP):** This is an inhibitory neurotransmitter that causes smooth muscle relaxation (e.g., lower esophageal sphincter) and stimulates intestinal water secretion. **High-Yield Clinical Pearls for NEET-PG:** * **Erythromycin Connection:** Erythromycin acts as a **motilin agonist**. It is used clinically in gastroparesis to stimulate GI motility by binding to motilin receptors. * **Phases of MMC:** It occurs every 90–120 minutes. **Phase III** is the most high-yield, characterized by intense, rhythmic contractions. * **Feeding:** The MMC is immediately abolished by the ingestion of food.
Explanation: **Explanation:** Secretin is a hormone produced by the **S-cells of the duodenum** in response to the entry of acidic chyme (pH < 4.5) from the stomach. Its primary physiological role is to neutralize this acid to protect the intestinal mucosa and provide an optimal pH for pancreatic enzymes. **1. Why Option A is the Correct (False) Statement:** Secretin **decreases** the acidity of biliary and pancreatic secretions; it does not increase it. It stimulates the ductal cells of the pancreas and the cholangiocytes of the biliary tree to secrete a fluid rich in **bicarbonate (HCO₃⁻)** and water. This alkaline secretion neutralizes gastric acid, making the secretions more basic (higher pH), not more acidic. **2. Analysis of Other Options:** * **Option B & C:** Secretin acts as an "enterogastrone." It inhibits gastric acid secretion by parietal cells and slows down gastric emptying (to ensure the duodenum isn't overwhelmed by acid). It also inhibits the release of Gastrin, effectively acting as a physiological brake on the stomach. * **Option D:** Secretin is a potent choleretic; it increases the volume, flow, and velocity of bile by stimulating bicarbonate-rich secretion from the bile ducts. **Clinical Pearls for NEET-PG:** * **Nature's Antacid:** Secretin is often called "Nature's Antacid." * **Mechanism:** It acts via **cAMP** as a second messenger. * **Secretin Stimulation Test:** Used in the diagnosis of **Zollinger-Ellison Syndrome (ZES)**. Paradoxically, secretin causes a massive increase in gastrin levels in ZES patients, whereas it inhibits gastrin in normal individuals. * **Potentiation:** Secretin and CCK (Cholecystokinin) augment each other's effects on the exocrine pancreas.
Explanation: **Explanation:** The success of Oral Rehydration Therapy (ORT) is based on the physiological principle of **solvent drag** and the specific mechanism of the **SGLT-1 (Sodium-Glucose Co-transporter 1)** located in the apical membrane of enterocytes. **1. Why Option B is Correct:** In most diarrheal diseases (like Cholera), the cAMP-mediated secretory pathways are activated, leading to massive fluid loss. However, the **glucose-coupled sodium transport** mechanism remains intact. When glucose and sodium are administered together (as in ORS), SGLT-1 transports them into the cell in a 1:1 ratio. This increases the intracellular osmotic pressure, which subsequently "drags" water from the intestinal lumen into the blood via the paracellular and transcellular pathways. This allows for rehydration even while active secretion is occurring. **2. Why Other Options are Incorrect:** * **Option A:** The Na+/K+ ATPase (Sodium pump) is located on the basolateral membrane, not the apical side. While it maintains the gradient, it is not the primary mechanism triggered by ORS to reverse dehydration. * **Option C:** While sodium is absorbed with bicarbonate in the ileum, this process is often inhibited or overwhelmed during secretory diarrhea and is not the primary driver of ORS efficacy. * **Option D:** Sodium absorption in ORT is an **active, carrier-mediated process** (secondary active transport), not simple passive diffusion. **Clinical Pearls for NEET-PG:** * **ORS Composition (WHO 1975 vs. Reduced Osmolarity):** The current WHO Reduced Osmolarity ORS has a total osmolarity of **245 mOsm/L** (Sodium: 75 mmol/L, Glucose: 75 mmol/L). * **SGLT-1 vs. GLUT-2:** SGLT-1 is for apical uptake (Na+ dependent); GLUT-2 is for basolateral exit (Na+ independent). * **Trisodium Citrate:** Added to ORS to correct metabolic acidosis and enhance sodium absorption.
Gastrointestinal Motility
Practice Questions
Gastrointestinal Secretions
Practice Questions
Digestion and Absorption
Practice Questions
Gastrointestinal Hormones
Practice Questions
Hepatobiliary Physiology
Practice Questions
Pancreatic Exocrine Function
Practice Questions
Gastrointestinal Circulation
Practice Questions
Intestinal Immune System
Practice Questions
Gut Microbiome
Practice Questions
Regulation of Food Intake
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free